Johnson & Johnson
JNJNYSE
$265.04
Last price · USD
- Market cap
- $643.9B
- P/E
- 24.0x
- EV / EBITDA
- 16.4x
- P/S
- 6.8x
- FCF yield
- 3.1%
- Div. yield
- 1.92%
Multiples use last price and FY2025 annual figures. Market cap estimated from diluted shares.
Johnson & Johnson income statement
Annual · USD millions except per-share data · 27 lines
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 | CAGR | |
|---|---|---|---|---|---|---|---|
| Revenue & gross profit | |||||||
| Revenue | 94,193 | 88,821 | 85,159 | 79,990 | 78,740 | +4.6% | |
| Cost of revenue | 30,256 | 27,471 | 26,553 | 24,596 | 23,402 | +6.6% | |
| Gross profit | 63,937 | 61,350 | 58,606 | 55,394 | 55,338 | +3.7% | |
| Operating expenses & income | |||||||
| Research & development | 14,665 | 17,232 | 15,085 | 14,135 | 14,277 | +0.7% | |
| General & administrative | 0 | 21,969 | 20,112 | 20,246 | 20,118 | — | |
| SG&A (combined) | 23,676 | 21,969 | 20,112 | 20,246 | 20,118 | +4.2% | |
| Total operating expenses | 38,341 | 39,201 | 35,197 | 34,381 | 34,395 | +2.8% | |
| Cost and expenses | 68,597 | 66,672 | 61,750 | 58,977 | 57,797 | +4.4% | |
| Operating income | 25,596 | 22,149 | 23,409 | 21,013 | 20,943 | +5.1% | |
| Non-operating & other | |||||||
| Interest income | 1,056 | 1,332 | 1,261 | 490 | 53 | +111.3% | |
| Interest expense | 971 | 755 | 772 | 276 | 183 | +51.8% | |
| Net interest income | 85 | 577 | 489 | 214 | (130) | — | |
| Non-operating income (excl. interest) | (7,956) | 4,707 | 7,575 | 1,378 | 1,582 | — | |
| Total other income (expenses), net | 6,985 | (5,462) | (8,347) | (1,654) | (1,765) | — | |
| Profitability | |||||||
| Depreciation & amortization | 7,503 | 7,339 | 7,486 | 6,970 | 7,390 | +0.4% | |
| Income before tax | 32,581 | 16,687 | 15,062 | 19,359 | 19,178 | +14.2% | |
| Income tax expense | 5,777 | 2,621 | 1,736 | 2,989 | 1,377 | +43.1% | |
| Net income from continuing operations | 26,804 | 14,066 | 13,326 | 16,370 | 17,801 | +10.8% | |
| Net income from discontinued operations | 0 | 0 | 21,827 | 1,571 | 3,077 | — | |
| Net income | 26,804 | 14,066 | 35,153 | 17,941 | 20,878 | +6.4% | |
| Bottom line net income | 26,804 | 14,066 | 35,153 | 17,941 | 20,878 | +6.4% | |
| Additional fields | |||||||
| Ebit | 33,552 | 17,442 | 15,834 | 19,635 | 19,361 | +14.7% | |
| Ebitda | 41,055 | 24,781 | 23,320 | 26,605 | 26,751 | +11.3% | |
| Eps | $11.03 | $5.84 | $13.88 | $6.83 | $7.93 | +8.6% | |
| Eps Diluted | $11.03 | $5.79 | $13.72 | $6.73 | $7.81 | +9.0% | |
| Weighted Average Shs Out | 2,429 | 2,407 | 2,534 | 2,614 | 2,629 | -2.0% | |
| Weighted Average Shs Out Dil | 2,429 | 2,429 | 2,560 | 2,664 | 2,674 | -2.4% | |